Skip to main content
SpringerLink
Log in
Book cover

37th Hemophilia Symposium pp 171–173Cite as

Successful Treatment of a Patient with High Titer Acquired Factor VIII Inhibitor (114 BU) with Rituximab

  • Conference paper

  • 694 Accesses

Abstract

Acquired hemophilia is a rare severe bleeding disorder caused by antibodies against coagulation factors. Factor VIII is the commonest factor affected.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia. A natural history study of 16 patient with factors receiving little or no therapy. Arch Intern Med 1987; 147:1077–81

    Article  PubMed  CAS  Google Scholar 

  2. Margolius A Jr, Jackson DP, Ratnoff OD. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore) 1961; 40: 145–202

    Article  PubMed  Google Scholar 

  3. Green D, Lechner K. A survey of 215 non-haemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981; 45: 200–3

    PubMed  CAS  Google Scholar 

  4. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463–7

    PubMed  CAS  Google Scholar 

  5. Field JJ, Fenske TS, Blinder MA. Rituximab fort the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Haemophilia 2007; 13: 46–50

    Article  PubMed  CAS  Google Scholar 

  6. Baudo F, Arnout J, Collins P, Huth-Kühne A, Levesque H, Knoebl P. The European Acquired Haemophilia (EACH) registry. Haemophilia 2006; 12:(Suppl.2), 1

    Google Scholar 

  7. Krause M, Kessel C, Von Auer C, Kreuz W, Scharrer I, Koenigs C. Response to anti CD 20 monoclonal antibody Rituximab and Epitope mapping of inhibitory antibodies in patients with acquired haemophilia. Haemophilia 2006; 12:(Suppl. 2), 2

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HELIOS-Klinik Erfurt, D-Erfurt

    Frau Dr. Ch. Schubert

Authors
  1. Frau Dr. Ch. Schubert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Herold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. 3. Med. Klinik, Gerinnungsambulanz, Universitätsklinik Mainz, Langenbeckstr. 1, 55131, Mainz, Germany

    Inge Scharrer

  2. Dept. of Hemostaseology, University Hospital Munich, Ziemssenstr. 1a, 80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schubert, C., Herold, M. (2008). Successful Treatment of a Patient with High Titer Acquired Factor VIII Inhibitor (114 BU) with Rituximab. In: Scharrer, I., Schramm, W. (eds) 37th Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73535-9_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-73535-9_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-73534-2

  • Online ISBN: 978-3-540-73535-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation